Cancer Control

1.8k papers and 33.8k indexed citations i.

About

The 1.8k papers published in Cancer Control in the last decades have received a total of 33.8k indexed citations. Papers published in Cancer Control usually cover Oncology (837 papers), Pulmonary and Respiratory Medicine (473 papers) and Surgery (385 papers) specifically the topics of Global Cancer Incidence and Screening (187 papers), Colorectal Cancer Screening and Detection (98 papers) and Gastric Cancer Management and Outcomes (91 papers). The most active scholars publishing in Cancer Control are Hilary Thomas, Helen M. Coley, Lodovico Balducci, Lary A. Robinson, Martine Extermann, Nader N. Massarweh, Hashem B. El‐Serag, Lee S. Rosen, Domenico Coppola and Lubomir Sokol.

In The Last Decade

Fields of papers published in Cancer Control

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Cancer Control. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Cancer Control

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Cancer Control. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Cancer Control with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025